Pancreatic cancer: Pathogenesis, prevention and treatment
- 1 November 2007
- journal article
- review article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 224 (3), 326-336
- https://doi.org/10.1016/j.taap.2006.11.007
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Gene Therapy Based on Gemcitabine Chemosensitization Suppresses Pancreatic Tumor GrowthMolecular Therapy, 2006
- Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.2006
- Vitamin D Intake and the Risk for Pancreatic Cancer in Two Cohort StudiesCancer Epidemiology, Biomarkers & Prevention, 2006
- Usage of the NF‐κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancerInternational Journal of Cancer, 2003
- Function of nuclear factor kappaB in pancreatic cancer metastasis.2003
- Resveratrol Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer CellsPancreas, 2002
- Suppression of Human Pancreatic Carcinoma Cell Growth and Invasion by Epigallocatechin-3-GallatePancreas, 2002
- Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.2000
- Green tea in chemoprevention of cancerToxicological Sciences, 1999
- Modulation of Pancreatic Carcinogenesis by AntioxidantsFood and Chemical Toxicology, 1999